Top Markets
Coin of the day
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
주식 순위 #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
주가
$1.73
시가총액
$42.88M
변동 (1일)
2.16%
변동 (1년)
-18.85%
국가
PL
거래 Molecure S.A. (MOC)

카테고리

Molecure S.A. (MOC)의 주가 이력
최고 종가: $1.72 (2026-08-01 기준)

최저 종가: $8.01 (2018-04-01 기준)
Molecure S.A.의 주가 이력 (2018 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -4.92%
2025 -23.76%
2024 -51.57%
2023 52.92%
2022 -63.44%
2021 -31.76%
2020 420.16%
2019 -41.51%
2018 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$539.98 36.93%
US
$1.03K 56.35%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$133.68 397.12%
US